We are live on ! Find out more
LBPSW

4D Pharma PLC Warrant
LBPSW

Delisted

LBPSW was delisted on the 29th of June, 2022.

6 hedge funds and large institutions have $315K invested in 4D Pharma PLC Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 56 (+1)

38% less capital invested

Capital invested by funds: $506K → $315K (-$191K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

LBPSW Hedge Fund Activity: Q3 2021 in Review

6 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q3 2021, worth a combined $315K — down 38% from $506K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LBPSW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $11.2K. The largest seller was AQR Arbitrage, cutting an estimated $11.4K.

  • 6 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q3 2021, up from 5 in Q2 2021.
  • Funds reported $315K of 4D Pharma PLC Warrant stock for Q3 2021, down 38% quarter-over-quarter.
  • 1 fund opened new 4D Pharma PLC Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
  • The largest 4D Pharma PLC Warrant buyer in Q3 2021 was Susquehanna International Group, an estimated $11.2K added.
  • The largest 4D Pharma PLC Warrant seller in Q3 2021 was AQR Arbitrage, an estimated $11.4K sold.

Based on aggregated 13F filings for Q3 2021.